Congestive heart failure and other cardiac adverse events after intravitreal anti-VEGF therapy: a systematic review and meta-analysis.

Vabysmo (faricimab-svoa) - Roche

Beovu (brolucizumab-dbll) - Novartis

Lucentis (ranibizumab) - Roche, Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42767615

Aaditeya Jhaveri; Andrew Mihalache; Marko M Popovic; Michael Balas; Peter J Kertes; Rajeev H Muni; Shayaan Kaleem

Sep 22, 2026